Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of rare diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development a... More >>
|Data as of Sep 15, 2019 2:02 PM EDT
Recent NewsMore >>
Upcoming EventsMore >>
|Wednesday, October 02, 2019 through Friday, October 04, 2019||
|Friday, November 08, 2019 through Tuesday, November 12, 2019||
There are currently no items available.